These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36966045)

  • 1. Corrigendum to "Chlorambucil-conjugated PI-polyamide (Chb-M'), a transcription inhibitor of the RUNX family, has anti-tumor activity against SHH-type medulloblastoma with p53 mutation" [Biochem. Biophys. Res. Commun. 620 (10 September 2022) 150-157].
    Matsui Y; Mineharu Y; Noguchi Y; Hattori EY; Kubota H; Hirata M; Miyamoto S; Sugiyama H; Arakawa Y; Kamikubo Y
    Biochem Biophys Res Commun; 2023 May; 656():146-147. PubMed ID: 36966045
    [No Abstract]   [Full Text] [Related]  

  • 2. Chlorambucil-conjugated PI-polyamides (Chb-M'), a transcription inhibitor of RUNX family, has an anti-tumor activity against SHH-type medulloblastoma with p53 mutation.
    Matsui Y; Mineharu Y; Noguchi Y; Hattori EY; Kubota H; Hirata M; Miyamoto S; Sugiyama H; Arakawa Y; Kamikubo Y
    Biochem Biophys Res Commun; 2022 Sep; 620():150-157. PubMed ID: 35792512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RUNX inhibitor suppresses graft-versus-host disease through targeting
    Kubota H; Masuda T; Noura M; Furuichi K; Matsuo H; Hirata M; Kataoka TR; Hiramatsu H; Yasumi T; Nakahata T; Imai Y; Takita J; Adachi S; Sugiyama H; Kamikubo Y
    EJHaem; 2021 Aug; 2(3):449-458. PubMed ID: 35844683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Alkylation of the RUNX-Binding Sequence by CBI-PI Polyamide Conjugates*.
    Maeda R; Ito S; Hashiya K; Bando T; Sugiyama H
    Chemistry; 2020 Nov; 26(64):14639-14644. PubMed ID: 32672369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of malignant rhabdoid tumors through Chb-M'-mediated RUNX1 inhibition.
    Daifu T; Mikami M; Hiramatsu H; Iwai A; Umeda K; Noura M; Kubota H; Masuda T; Furuichi K; Takasaki S; Noguchi Y; Morita K; Bando T; Hirata M; Kataoka TR; Nakahata T; Kuwahara Y; Iehara T; Hosoi H; Takita J; Sugiyama H; Adachi S; Kamikubo Y
    Pediatr Blood Cancer; 2021 Feb; 68(2):e28789. PubMed ID: 33180377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Functional loss of TAGLN inhibits tumor growth and increases chemosensitivity of non-small cell lung cancer" [Biochem. Biophys. Res. Commun. 529 (4) (3 September 2020) 1086-1093].
    Fu J; Wang X; Yue Q
    Biochem Biophys Res Commun; 2021 Feb; 541():102. PubMed ID: 33478719
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to 'The C-terminus of ubiquitin plays a critical role in deamidase Lpg2148 recognition.' [Biochem. Biophys. Res. Commun. 503(4), 18 September 2018, 2943-2948].
    Zhu M; Ma X; Gao Y; Li X; Ke J; Khan MH; Teng M; Ge H; Zhu Z; Niu L
    Biochem Biophys Res Commun; 2018 Oct; 505(2):633. PubMed ID: 30243727
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling" [Biochem. Biophys. Res. Commun. 524 (1) (2020) 1-7].
    Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
    Biochem Biophys Res Commun; 2021 Jan; 536():115. PubMed ID: 33390248
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to 'Revisit the effect of fibrillization on functions of prion protein from the perspective of Cu(II) binding' [Biochem. Biophys. Res. Commun. vol. 503 (1) (3 September 2018) 32-37].
    Qi X; McGuirl M
    Biochem Biophys Res Commun; 2018 Sep; 504(1):359. PubMed ID: 30139520
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "TTK inhibitor promotes radiosensitivity of liver cancer cells through p21" [Biochem. Biophys. Res. Commun. 550(2021) 84-91].
    Zhang H; Yao W; Zhang M; Lu Y; Tang J; Jiang M; Mou X; You G; Liang X
    Biochem Biophys Res Commun; 2021 May; 555():214. PubMed ID: 33840464
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Structure-based molecular characterization of the LltR transcription factor from Listeria monocytogenes" [Biochem. Biophys. Res. Commun. 600(2022) 142-149].
    Kim J; Park J; Choi Z; Hong M
    Biochem Biophys Res Commun; 2022 Jun; 609():197. PubMed ID: 35487771
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to ‟Autophagy prevention sensitizes AKTi-1/2-induced anti-hepatocellular carcinoma cell activity in vitro and in vivo" [Biochem. Biophys. Res. Commun. (2016) 480(3) 334-340].
    Zhang Q; Yang M; Qu Z; Zhou J; Jiang Q
    Biochem Biophys Res Commun; 2021 Aug; 565():99. PubMed ID: 33962803
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "The SIRT2 inhibitor AK-7 decreases cochlear cell apoptosis and attenuates noise-induced hearing loss" [Biochem. Biophys. Res. Commun. 509 (3) (2019) 641-646].
    Liu Y; Ao L; Li Y; Zhao Y; Wen Y; Ding H
    Biochem Biophys Res Commun; 2019 Mar; 511(1):201. PubMed ID: 30773260
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "A novel firefly luciferase biosensor enhances the detection of apoptosis induced by ESAT-6 family proteins of Mycobacterium tuberculosis" [Biochem. Biophys. Res. Commun. 452 (4) (2014) 1046-1053].
    Shi J; Zhang H; Fang L; Xi Y; Zhou Y; Luo R; Wang D; Xiao S; Chen H
    Biochem Biophys Res Commun; 2020 Feb; 522(4):1069-1070. PubMed ID: 31952792
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Progranulin protects against cerebral ischemia-reperfusion (I/R) injury by inhibiting necroptosis and oxidative stress" [Biochem. Biophys. Res. Commun. 521 (315) (2020) 569-576].
    Li X; Cheng S; HaoHu ; Zhang X; JiehuaXu ; Wang R; Zhang P
    Biochem Biophys Res Commun; 2020 May; 525(3):822. PubMed ID: 32171520
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Modelling urea-cycle disorder citrullinemia type 1 with disease-specific iPSCs" [Biochem. Biophys. Res. Commun. 486(3) (2017) 613-619].
    Yoshitoshi-Uebayashi EY; Toyoda T; Yasuda K; Kotaka M; Nomoto K; Okita K; Yasuchika K; Okamoto S; Takubo N; Nishikubo T; Soga T; Uemoto S; Osafune K
    Biochem Biophys Res Commun; 2017 Jul; 488(3):570-571. PubMed ID: 28528898
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "β-arrestins negatively control human adrenomedullin type 1-receptor internalization" [Biochem. Biophys. Res. Commun. 487 (2) (2017) 438-443].
    Kuwasako K; Kitamura K; Nagata S; Sekiguchi T; Jiang D; Murakami M; Hattori Y; Kato J
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1139. PubMed ID: 28610829
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Cell type-specific roles of Jak3 in IL-2-induced proliferative signal transduction" [Biochem. Biophys. Res. Commun. 354 (3) (2007) 825-829].
    Fujii H
    Biochem Biophys Res Commun; 2021 May; 552():196. PubMed ID: 33722377
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Netrin-1 promotes metastasis of gastric cancer by regulating YAP activity" [Biochem. Biophys. Res. Commun. 496 (1) (2018 Jan 29) 76-82].
    Yin K; Dang S; Cui L; Fan X; Xie R; Qu J; Shang M; Chen J
    Biochem Biophys Res Commun; 2018 Mar; 498(1):262. PubMed ID: 29506865
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Combined usage of monosaccharides with polysaccharides may decelerate tumor growth and malignance versus solely using a certain kind of saccharide" [Biochem. Biophys. Res. Commun. (2020) 525(3) 800-805].
    Yu C; Lv B; Min S; Ren L; Yu J
    Biochem Biophys Res Commun; 2020 Oct; 531(3):443. PubMed ID: 32854943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.